title: The management of herpes simplex virus infections.
abstract: Herpes simplex virus persists in a latent form for the life of its host, periodically reactivating and often resulting in significant psychosocial distress for the patient. Currently no cure is available. Antiviral therapy is the main treatment modality, used either orally, intravenously, or topically to prohibit further replication of the virus and thereby minimize cellular destruction. However, immunologic advances in the treatment and prevention of herpes simplex infections are promising and continue to be studied.
authors.affiliation: Department of Dermatology, University of Texas Medical Branch-Galveston, Galveston, Texas, USA.
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Yeung-Yue
authors.forename: Mathijs H
authors.initials: MH
authors.lastname: Brentjens
authors.forename: Patricia C
authors.initials: PC
authors.lastname: Lee
authors.forename: Stephen K
authors.initials: SK
authors.lastname: Tyring
mesh_terms: D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D006561:Herpes Simplex / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D022301:Herpes Simplex Virus Vaccines / Q000276:immunology; D006801:Humans; D018139:Simplexvirus / Q000187:drug effects / Q000472:pathogenicity / Q000502:physiology
chemical_list: D000998:Antiviral Agents; D022301:Herpes Simplex Virus Vaccines